
PMC:7291971 / 22531-25169
Annnotations
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T502 | 39-48 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
T503 | 57-65 | SP_10 | denotes | SARS-CoV |
T504 | 66-71 | PR:000000125 | denotes | nsp14 |
T505 | 76-81 | PR:O43148 | denotes | hRNMT |
T506 | 125-132 | CHEBI:28748;CHEBI:28748 | denotes | adenine |
T507 | 133-146 | CHEBI:23447;CHEBI:23447 | denotes | dinucleosides |
T508 | 155-163 | SP_10 | denotes | SARS-CoV |
T509 | 201-210 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
T510 | 303-312 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
T511 | 378-386 | SP_10 | denotes | SARS-CoV |
T512 | 459-472 | CHEBI:23447;CHEBI:23447 | denotes | dinucleosides |
T513 | 526-535 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
T514 | 651-659 | SP_10 | denotes | SARS-CoV |
T515 | 733-743 | CHEBI:35222;CHEBI:35222 | denotes | inhibitors |
T516 | 751-760 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
T517 | 814-822 | SP_10 | denotes | SARS-CoV |
T518 | 1008-1016 | SP_10 | denotes | SARS-CoV |
T519 | 1017-1022 | PR:000000125 | denotes | nsp14 |
T520 | 1060-1069 | CHEBI:35222;CHEBI:35222 | denotes | inhibitor |
T521 | 1113-1121 | CHEBI:36357;CHEBI:36357 | denotes | compound |
T522 | 1163-1171 | SP_10 | denotes | SARS-CoV |
T523 | 1275-1280 | PR:O43148 | denotes | hRNMT |
T524 | 1311-1319 | CHEBI:33910;CHEBI:33910 | denotes | chlorine |
T525 | 1320-1324 | CHEBI:33250;CHEBI:33250 | denotes | atom |
T526 | 1350-1361 | CHEBI:29785;CHEBI:29785 | denotes | nitro group |
T527 | 1508-1513 | CHEBI:53325;CHEBI:53325 | denotes | nitro |
T528 | 1551-1556 | CHEBI:24433;CHEBI:24433 | denotes | group |
T529 | 1664-1675 | CHEBI:29785;CHEBI:29785 | denotes | nitro group |
T530 | 1683-1689 | CHEBI:30396;CHEBI:30396 | denotes | phenyl |
T531 | 1779-1787 | CHEBI:33910;CHEBI:33910 | denotes | chlorine |
T532 | 1788-1792 | CHEBI:33250;CHEBI:33250 | denotes | atom |
T533 | 1834-1845 | CHEBI:29785;CHEBI:29785 | denotes | nitro group |
T534 | 1877-1885 | SP_10 | denotes | SARS-CoV |
T535 | 1886-1891 | PR:000000125 | denotes | nsp14 |
T536 | 1965-1974 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
T537 | 1978-1986 | SP_10 | denotes | SARS-CoV |
T538 | 1997-2002 | SP_6;NCBITaxon:9606 | denotes | human |
T539 | 2039-2044 | PR:000000125 | denotes | nsp14 |
T31576 | 2005-2014 | CHEBI:36357;CHEBI:36357 | denotes | MT activi |
T67246 | 2042-2050 | SP_10 | denotes | 14 IC50a |
T8618 | 2051-2056 | PR:000000125 | denotes | (μM) |
T22326 | 2094-2103 | CHEBI:35222;CHEBI:35222 | denotes | 2 40.6 ± |
T4976 | 2151-2159 | SP_10 | denotes | 0 10 3.9 |
T14252 | 2202-2211 | CHEBI:36357;CHEBI:36357 | denotes | .7 ± 0.5 |
T88128 | 2295-2304 | CHEBI:35222;CHEBI:35222 | denotes | 9 n.d a C |
T62427 | 2384-2393 | CHEBI:35222;CHEBI:35222 | denotes | experime |
T17572 | 2433-2441 | SP_10 | denotes | The MTas |
T56144 | 2628-2636 | CHEBI:36357;CHEBI:36357 | denotes | at 50 μ |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T78 | 125-132 | Body_part | denotes | adenine | http://purl.org/sig/ont/fma/fma82774 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
424 | 125-146 | Chemical | denotes | adenine dinucleosides | |
425 | 459-472 | Chemical | denotes | dinucleosides | |
426 | 1070-1080 | Chemical | denotes | sinefungin | MESH:C006235 |
427 | 1241-1251 | Chemical | denotes | sinefungin | MESH:C006235 |
428 | 1311-1319 | Chemical | denotes | chlorine | MESH:D002713 |
429 | 1350-1355 | Chemical | denotes | nitro | |
430 | 1508-1513 | Chemical | denotes | nitro | |
431 | 1664-1669 | Chemical | denotes | nitro | |
432 | 1779-1787 | Chemical | denotes | chlorine | MESH:D002713 |
433 | 1834-1839 | Chemical | denotes | nitro |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T58 | 57-65 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T59 | 155-163 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T60 | 378-386 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T61 | 651-659 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T62 | 814-822 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T63 | 1008-1016 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T64 | 1163-1171 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T65 | 1877-1885 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T66 | 1978-1986 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T67 | 2030-2038 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T183 | 19-26 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | testing |
T184 | 191-197 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tested |
T185 | 214-215 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T186 | 275-277 | http://purl.obolibrary.org/obo/CLO_0008922 | denotes | S2 |
T187 | 275-277 | http://purl.obolibrary.org/obo/CLO_0050052 | denotes | S2 |
T188 | 484-492 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T189 | 699-707 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T190 | 770-772 | http://purl.obolibrary.org/obo/CLO_0053733 | denotes | 11 |
T191 | 802-810 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T192 | 1177-1178 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T193 | 1225-1232 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | testing |
T194 | 1260-1266 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | active |
T195 | 1282-1284 | http://purl.obolibrary.org/obo/CLO_0053733 | denotes | 11 |
T196 | 1309-1310 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T197 | 1348-1349 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T198 | 1538-1539 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T199 | 1662-1663 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T200 | 1720-1728 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T201 | 1832-1833 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T202 | 1903-1911 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T203 | 1958-1964 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | active |
T204 | 1997-2002 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T205 | 2008-2018 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activities |
T206 | 2171-2173 | http://purl.obolibrary.org/obo/CLO_0053733 | denotes | 11 |
T207 | 2301-2302 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T208 | 2334-2342 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T209 | 2398-2399 | http://purl.obolibrary.org/obo/CLO_0001021 | denotes | b |
T210 | 2428-2430 | http://purl.obolibrary.org/obo/CLO_0053733 | denotes | 11 |
T211 | 2443-2451 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T212 | 2495-2496 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T401 | 125-132 | Chemical | denotes | adenine | http://purl.obolibrary.org/obo/CHEBI_16708 |
T402 | 275-277 | Chemical | denotes | S2 | http://purl.obolibrary.org/obo/CHEBI_29387 |
T403 | 733-743 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
T404 | 1060-1069 | Chemical | denotes | inhibitor | http://purl.obolibrary.org/obo/CHEBI_35222 |
T405 | 1070-1080 | Chemical | denotes | sinefungin | http://purl.obolibrary.org/obo/CHEBI_45453 |
T406 | 1241-1251 | Chemical | denotes | sinefungin | http://purl.obolibrary.org/obo/CHEBI_45453 |
T407 | 1311-1324 | Chemical | denotes | chlorine atom | http://purl.obolibrary.org/obo/CHEBI_23116 |
T408 | 1311-1319 | Chemical | denotes | chlorine | http://purl.obolibrary.org/obo/CHEBI_29310 |
T409 | 1320-1324 | Chemical | denotes | atom | http://purl.obolibrary.org/obo/CHEBI_33250 |
T410 | 1350-1361 | Chemical | denotes | nitro group | http://purl.obolibrary.org/obo/CHEBI_29785 |
T411 | 1356-1361 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
T412 | 1508-1513 | Chemical | denotes | nitro | http://purl.obolibrary.org/obo/CHEBI_29785 |
T413 | 1551-1556 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
T414 | 1664-1675 | Chemical | denotes | nitro group | http://purl.obolibrary.org/obo/CHEBI_29785 |
T415 | 1670-1675 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
T416 | 1683-1689 | Chemical | denotes | phenyl | http://purl.obolibrary.org/obo/CHEBI_30396 |
T417 | 1779-1792 | Chemical | denotes | chlorine atom | http://purl.obolibrary.org/obo/CHEBI_23116 |
T418 | 1779-1787 | Chemical | denotes | chlorine | http://purl.obolibrary.org/obo/CHEBI_29310 |
T419 | 1788-1792 | Chemical | denotes | atom | http://purl.obolibrary.org/obo/CHEBI_33250 |
T420 | 1834-1845 | Chemical | denotes | nitro group | http://purl.obolibrary.org/obo/CHEBI_29785 |
T421 | 1840-1845 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32563813-28676301-29105587 | 1282-1284 | 28676301 | denotes | 11 |
32563813-28676301-29105588 | 2428-2430 | 28676301 | denotes | 11 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T157 | 0-81 | Sentence | denotes | 2.4 Dose-response testing of selected compounds against SARS-CoV nsp14 and hRNMT |
T158 | 82-279 | Sentence | denotes | To confirm the observed inhibition of some adenine dinucleosides against SARS-CoV nsp14 N7-MTase, we further tested 10 compounds in a dose-response assay (Table 2 , Supporting Information Fig. S2). |
T159 | 280-403 | Sentence | denotes | The selection of these compounds was based on their percentage inhibition higher than 50% against SARS-CoV nsp14 (Table 1). |
T160 | 404-513 | Sentence | denotes | After pre-incubation with increasing concentrations of dinucleosides, the MTase activity was measured by FBA. |
T161 | 514-708 | Sentence | denotes | The IC50 of compounds, deduced from Hill slope equation (Y = 100/(1+((X/IC50)^Hillslope) curve-fitting, ranged from 0.6 μM to 70.4 μM on SARS-CoV nsp14 and 10.9 μM to > 500 μM on hRNMT activity. |
T162 | 709-963 | Sentence | denotes | Among all the potential inhibitors, three compounds 2, 6 and 11 showed the lowest inhibitory activity on SARS-CoV nsp14 with IC50 > 40 μM, the others have IC50 values in the micromolar range except 13 that showed an IC50 value in the submicromolar range. |
T163 | 964-1081 | Sentence | denotes | The potency of the derivative 13 to inhibit SARS-CoV nsp14 was comparable to the broad spectrum inhibitor sinefungin. |
T164 | 1082-1286 | Sentence | denotes | However, it is noteworthy that compound 13 specifically inhibits the N7-MTase of SARS-CoV with a high 413-fold of specificity in dose-response testing whereas sinefungin is also active against hRNMT [11]. |
T165 | 1287-1587 | Sentence | denotes | Remarkably 13 bearing a chlorine atom in “para” position and a nitro group in “meta” position displayed the best inhibition which was 6.5–9.5 fold more potent than the derivatives 10 and 12, respectively that contain the nitro in “ortho” position and a lipophilic group CF3 or MeO in “para” position. |
T166 | 1588-1747 | Sentence | denotes | The comparison of IC50 values of 14 and 13 indicates that the addition of a nitro group in the phenyl ring increased the inhibitory activity by 2.5 fold in 13. |
T167 | 1748-1912 | Sentence | denotes | These results confirm that the chlorine atom in “para” position and the presence of a nitro group seem crucial for submicromolar SARS-CoV nsp14 inhibitory activity. |
T168 | 1913-2019 | Sentence | denotes | Table 2 Comparison of IC50 values of 10 most active compounds on SARS-CoV nsp14 and human RNMT activities. |
T169 | 2020-2070 | Sentence | denotes | Compounds SARS-CoV nsp14 IC50a (μM) hRNMTIC50 (μM) |
T170 | 2071-2093 | Sentence | denotes | Sinefunginb 0.36 <0.05 |
T171 | 2094-2117 | Sentence | denotes | 2 40.6 ± 3.2 10.9 ± 1.0 |
T172 | 2118-2135 | Sentence | denotes | 6 55.5 ± 5.1 >500 |
T173 | 2136-2152 | Sentence | denotes | 9 2.6 ± 0.2 >500 |
T174 | 2153-2170 | Sentence | denotes | 10 3.9 ± 0.4 >500 |
T175 | 2171-2197 | Sentence | denotes | 11 70.4 ± 4.9 169.3 ± 30.4 |
T176 | 2198-2223 | Sentence | denotes | 12 5.7 ± 0.5 275.9 ± 28.7 |
T177 | 2224-2249 | Sentence | denotes | 13 0.6 ± 0.1 247.5 ± 14.9 |
T178 | 2250-2266 | Sentence | denotes | 14 1.5 ± 0.1 n.d |
T179 | 2267-2283 | Sentence | denotes | 15 2.4 ± 0.2 n.i |
T180 | 2284-2300 | Sentence | denotes | 16 9.9 ± 0.9 n.d |
T181 | 2301-2397 | Sentence | denotes | a Concentration inhibiting MTase activity by 50%; mean value from three independent experiments. |
T182 | 2398-2432 | Sentence | denotes | b values from the literature [11]. |
T183 | 2433-2638 | Sentence | denotes | The MTase activity for IC50 determinations was measured using a filter binding assay as described above. n.i: no inhibition detected at 50 μM; n.d: not determined due to inhibition lower than 50% at 50 μM. |
MyTest
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32563813-28676301-29105587 | 1282-1284 | 28676301 | denotes | 11 |
32563813-28676301-29105588 | 2428-2430 | 28676301 | denotes | 11 |